Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma ; volume:147 ; number:8 ; day:8 ; month:5 ; year:2021 ; pages:2271-2280 ; date:8.2021
Journal of cancer research and clinical oncology ; 147, Heft 8 (8.5.2021), 2271-2280, 8.2021
- Urheber
-
Hölzl, Dorothee
Hutarew, Georg
Zellinger, Barbara
Schlicker, Hans U.
Schwartz, Christoph
Winkler, Peter A.
Sotlar, Karl
Kraus, Theo F. J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-021-03656-w
- URN
-
urn:nbn:de:101:1-2021101010561496469005
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hölzl, Dorothee
- Hutarew, Georg
- Zellinger, Barbara
- Schlicker, Hans U.
- Schwartz, Christoph
- Winkler, Peter A.
- Sotlar, Karl
- Kraus, Theo F. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multifocal high-grade glioma radiotherapy safety and efficacy
Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
Programmed death-ligand 1 expression in rectal cancer
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Status of programmed death-ligand 1 expression in sarcomas
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
Programmed death-ligand 1 expression in carcinoma of unknown primary
Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers
Multifocal high-grade glioma radiotherapy safety and efficacy
Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
Programmed death-ligand 1 expression in rectal cancer
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Status of programmed death-ligand 1 expression in sarcomas
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
Programmed death-ligand 1 expression in carcinoma of unknown primary
Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers
Multifocal high-grade glioma radiotherapy safety and efficacy
Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
Programmed death-ligand 1 expression in rectal cancer
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Status of programmed death-ligand 1 expression in sarcomas
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
Programmed death-ligand 1 expression in carcinoma of unknown primary